MMR, Wakefield and The Lancet: what can we learn?

Julie Leask, Robert Booy and Peter B McIntyre
Med J Aust 2010; 193 (1): . || doi: 10.5694/j.1326-5377.2010.tb03730.x
Published online: 5 July 2010

Vaccine scares are inevitable and we need to plan accordingly

Twelve years after The Lancet published the study by Wakefield and colleagues1 that suggested a link between measles–mumps–rubella (MMR) vaccination, inflammatory bowel disease and autism, the journal has fully retracted the article. The retraction followed the findings of the Fitness to Practise Panel of the UK General Medical Council, released 28 January 2010, that certain statements in the article were false — namely, that children were “consecutively referred” and that investigations were “approved” by the local ethics committee.2

  • Julie Leask1
  • Robert Booy2
  • Peter B McIntyre3

  • National Centre for Immunisation Research and Surveillance, Discipline of Paediatrics and Child Health, University of Sydney, Sydney, NSW.


Competing interests:

Julie Leask is involved in an influenza vaccination study which receives support from Sanofi Pasteur. Peter McIntyre receives support from GlaxoSmithKline and Wyeth for National Health and Medical Research Council clinical trials. Robert Booy occasionally receives funding from CSL, Roche, sanofi-aventis, GlaxoSmithKline and Wyeth for clinical trials, and to attend and present at scientific meetings. Any funding he receives is directed to a research account at the Children’s Hospital at Westmead and is not personally accepted by him.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.